Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From single-sequences to evolutionary trajectories: protein language models capture the evolutionary potential of SARS-CoV-2.

Nature communications·2026
Same author

Taxonomic expansion and reorganization of Flaviviridae.

Nature microbiology·2025
Same author

Viro3D: a comprehensive database of virus protein structure predictions.

Molecular systems biology·2025
Same author

Enhanced variant neutralization through glycan masking of SARS-CoV-2 XBB1.5 RBD.

Emerging microbes & infections·2025
Same author

Pathogen genomic surveillance and the AI revolution.

Journal of virology·2025
Same author

Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic.

Nature microbiology·2025

Related Experiment Video

Updated: Aug 8, 2025

Swabbing the Urban Environment - A Pipeline for Sampling and Detection of SARS-CoV-2 From Environmental Reservoirs
07:13

Swabbing the Urban Environment - A Pipeline for Sampling and Detection of SARS-CoV-2 From Environmental Reservoirs

Published on: April 9, 2021

4.3K

Low hanging fruit for combatting SARS-CoV-2?

Diego Cantoni1, Joe Grove1

  • 1MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, UK.

EMBO Reports
|March 6, 2023
PubMed
Summary
This summary is machine-generated.

Vitamin C targets the angiotensin-converting enzyme-2 (ACE2) receptor, crucial for SARS-CoV-2 entry into cells. This action leads to the degradation of ACE2, inhibiting viral infection and offering a potential therapeutic strategy.

More Related Videos

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro
09:26

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro

Published on: June 6, 2025

471
Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP
05:34

Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP

Published on: September 8, 2023

842

Related Experiment Videos

Last Updated: Aug 8, 2025

Swabbing the Urban Environment - A Pipeline for Sampling and Detection of SARS-CoV-2 From Environmental Reservoirs
07:13

Swabbing the Urban Environment - A Pipeline for Sampling and Detection of SARS-CoV-2 From Environmental Reservoirs

Published on: April 9, 2021

4.3K
Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro
09:26

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro

Published on: June 6, 2025

471
Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP
05:34

Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP

Published on: September 8, 2023

842

Area of Science:

  • Virology
  • Cell Biology
  • Nutritional Science

Background:

  • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) utilizes the angiotensin-converting enzyme-2 (ACE2) receptor for cellular entry.
  • ACE2 is a critical target for developing therapeutic interventions against COVID-19.
  • Understanding ACE2 regulation is key to combating coronavirus infections.

Purpose of the Study:

  • To investigate the effect of vitamin C on ACE2 expression and its role in SARS-CoV-2 infection.
  • To identify novel mechanisms regulating cellular ACE2.
  • To explore vitamin C as a potential therapeutic agent against SARS-CoV-2.

Main Methods:

  • Cellular assays to measure ACE2 levels and SARS-CoV-2 entry.
  • Ubiquitination assays to assess ACE2 protein degradation.
  • Treatment of cells with vitamin C and subsequent viral challenge.

Main Results:

  • Vitamin C treatment leads to ubiquitin-dependent degradation of ACE2.
  • Degradation of ACE2 by vitamin C significantly inhibits SARS-CoV-2 infection.
  • The study elucidates a new pathway for ACE2 regulation.

Conclusions:

  • Vitamin C can reduce ACE2 levels, thereby inhibiting SARS-CoV-2 cellular entry.
  • This finding suggests a potential role for vitamin C in managing COVID-19.
  • The identified mechanism may inform the development of new therapies for coronaviruses.